Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tetracycline Prophylaxis for Afatinib-Induced Rash in NSCLC
NCT01880515Phase 2Completed
- Start
- Dec 2010
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of tetracycline in skin rash (2 arms). Primary endpoint: Frequency of Participants Who Experienced Any Grade of Rash at 8 weeks. Started Dec 2010; status: completed.
02
Drugs
tetracycline
03
Conditions
skin rash
Beyond the preview
Go deeper on NCT01880515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01880515.